Skip to content
DraconiticResearch
Search Sources API
184,937 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BYDrug Design, Development and Therapy

Is the Benefit of High-Potency Progestins for Endometrial Hyperplasia Specific to Diminished Ovarian Reserve? [Letter]

  • Ye T1
  1. 1Department of Laboratory Medicine
Read full textCite

Abstract

Ting YeDepartment of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of ChinaCorrespondence: Ting Ye, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Jiangyang District, Luzhou, Sichuan, 646000, People’s Republic of China, Email [email protected]

Related

  1. Interobserver agreement in the diagnosis of endometrial atypical hyperplasia and the contribution of PTEN immunohistochemistry
    Romain Heritier, Matthieu Tihy, Berengere Tate +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  2. Sentinel Lymph Node Assessment in Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia: An Updated Systematic Review and Meta-Analysis.
    Pei-Chen Li, Dah-Ching Ding
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMC
  3. Estradiol valerate-induced endometrial hyperplasia is associated with oxidative stress and inflammatory activation
    Alyaa Abdelmonaem, Eman Kenawy, Maha Mickel +4
    Minia Journal of Medical ResearchPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ
  4. Cytomorphological criteria for the differential diagnosis of endometrial hyperplasia and endometrial cancer
    V.O. Sytnikova, S.O. Bashtan, I.Z. Gladchuk +1
    Репродуктивная эндокринологияPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ
  5. Metformin as an Adjunct to Fertility-Sparing Treatment in Atypical Endometrial Hyperplasia and Early-Stage Endometrioid Endometrial Cancer: Narrative Review.
    Angel Yordanov, Eva Tsoneva, Stoyan Kostov +2
    CancersPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ye2026benefit,
  title = {{Is the Benefit of High-Potency Progestins for Endometrial Hyperplasia Specific to Diminished Ovarian Reserve? [Letter]}},
  author = {Ye T},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  month = oct,
  url = {https://www.dovepress.com/is-the-benefit-of-high-potency-progestins-for-endometrial-hyperplasia--peer-reviewed-fulltext-article-DDDT},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Is the Benefit of High-Potency Progestins for Endometrial Hyperplasia Specific to Diminished Ovarian Reserve? [Letter]
AU  - Ye T
PY  - 2026
DA  - 2026/10/01
JO  - Drug Design, Development and Therapy
UR  - https://www.dovepress.com/is-the-benefit-of-high-potency-progestins-for-endometrial-hyperplasia--peer-reviewed-fulltext-article-DDDT
AB  - Ting YeDepartment of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of ChinaCorrespondence: Ting Ye, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Jiangyang District, Luzhou, Sichuan, 646000, People’s Republic of China, Email [email protected]
SN  - 1177-8881
ER  -